Abstract:Strong consensus exists regarding the most robust environmental intervention for attenuating aging processes and increasing healthspan and lifespan: calorie restriction (CR). Over several decades, this paradigm has been replicated in numerous nonhuman models, and has been expanded over the last decade to formal, controlled human studies of CR. Given that long-term CR can create heavy challenges to compliance in human diets, the concept of a calorie restriction mimetic (CRM) has emerged as an active research area within gerontology. In past presentations on this subject, we have proposed that a CRM is a compound that mimics metabolic, hormonal, and physiological effects of CR, activates stress response pathways observed in CR and enhances stress protection, produces CR-like effects on longevity, reduces age-related disease, and maintains more youthful function, all without significantly reducing food intake, at least initially. Over 16 years ago, we proposed that glycolytic inhibition could be an effective strategy for developing CRM. The main argument here is that inhibiting energy utilization as far upstream as possible provides the highest chance of generating a broad spectrum of CR-like effects when compared to targeting a singular molecular target downstream. As an initial candidate CRM, 2-deoxyglucose, a known anti-glycolytic, was shown to produce a remarkable phenotype of CR, but further investigation found that this compound produced cardiotoxicity in rats at the doses we had been using. There remains interest in 2DG as a CRM but at lower doses. Beyond the proposal of 2DG as a candidate CRM, the field has grown steadily with many investigators proposing other strategies, including novel anti-glycolytics. Within the realm of upstream targeting at the level of the digestive system, research has included bariatric surgery, inhibitors of fat digestion/absorption, and inhibitors of carbohydrate digestion. Research focused on downstream sites has included insulin receptors, IGF-1 receptors, sirtuin activators, inhibitors of mTOR, and polyamines. In the current review we discuss progress made involving these various strategies and comment on the status and future for each within this exciting research field.

Cyclic Amp Mimics the Anti-Ageing Effects of Calorie Restriction by Up-Regulating Sirtuin

Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells.

Advances in Sirtuin on the Mechanism of Calorie Restriction on Lifespan*

Calorie Restriction is the Most Reasonable Anti-Ageing Intervention: a Meta-Analysis of Survival Curves

Lithocholic Acid Phenocopies Rejuvenating and Life-Extending Effects of Calorie Restriction

Calorie restriction and calorie-restriction mimetics activate chaperone-mediated autophagy

Reducing Sphingolipid Synthesis Orchestrates Global Changes To Extend Yeast Lifespan

AMPK-PDZD8-GLS1 axis mediates calorie restriction-induced lifespan extension

SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases

Calorie restriction mimetics: Can you have your cake and eat it, too?

Sirtuins at the Service of Healthy Longevity

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

Caloric restriction mimetics——A new territory in aging intervention

Caloric restriction, Sirtuins, and cardiovascular diseases

A small‐molecule screen identifies novel aging modulators by targeting 5‐HT/DA signaling pathway

ACS-20/FATP4 mediates the anti-ageing effect of dietary restriction in C. elegans

SIRT1, resveratrol and aging

AMPK activation can delay aging

Lithocholic Acid Targets TULP3 to Activate Sirtuins and AMPK to Retard Ageing

[Anti-aging traditional Chinese medicine： potential mechanisms involving AMPK pathway and calorie restriction based on "medicine-food homology" theory]

Ginsenoside Rg1 Delays Chronological Aging in a Yeast Model Via CDC19- and SDH2-Mediated Cellular Metabolism.